The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma
识别出一小部分但意义重大的患者亚群，这些患者在罹患三阴性乳腺癌时仍可使用抗HER2抑制剂进行治疗。
期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-013-1479-0
Brunello, Eleonora; Bogina, Giuseppe; Bria, Emilio; Vergine, Marco; Zamboni, Giuseppe; Pedron, Serena; Daniele, Isabella; Furlanetto, Jenny; Carbognin, Luisa; Marconi, Marcella; Manfrin, Erminia; Ibrahim, Merdol; Miller, Keith; Tortora, Giampaolo; Molino, Annamaria; Jasani, Bharat; Beccari, Serena; Bonetti, Franco; Chilosi, Marco; Martignoni, Guido; Brunelli, Matteo
